Skip to content

13F-HR filed by Trustees of Columbia University in the City of New York

Trustees of Columbia University in the City of New York filed this 13F-HR for the quarter ended 2024-12-31, filed 2025-02-14, with 13 holding rows worth $633,736,745.

Accession
0000904454-25-000140
Filed
2025-02-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2024

A holdings report, 13 entries on the cover page, a total value of $633,736,745 stated on the cover page (in dollars after the unit check, H1), rows summing to $633,736,745 with VALUE read as dollars as filed, 13F file number 028-20933. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
SPY78462F103SHS1,071,799$628,159,958dollars as filed
SNOWFLAKE INC COM SHS833445109Stock10,645$1,643,694dollars as filed
NU HLDGS LTDG6683N103ORD SHS CL A108,588$1,124,972dollars as filed
SURROZEN INC86889P208COMMON STOCK47,930$687,796dollars as filed
Q32 BIO INC746964105Common Stock133,903$460,626dollars as filed
TENAYA THERAPEUTICS INC87990A106COM291,828$417,314dollars as filed
VIGIL NEUROSCIENCE INC92673K108COM192,973$328,054dollars as filed
RILEY EXPLORATION PERMIAN IN76665T102COM7,503$239,496dollars as filed
Xilio Therapeutics Inc.98422T100COM249,635$238,401dollars as filed
RAMACO RES INC75134P600COM CL A21,225$217,769dollars as filed
RAPT THERAPEUTICS INC75382E109COM73,383$115,945dollars as filed
VOR BIOPHARMA INC929033108COM91,910$102,020dollars as filed
SURROZEN INC86889P117*W EXP 08/01/20333,333$700dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0000904454-25-000140this filing2025-02-14acceptance time not in the bulk data set